Skip to main navigation Skip to search Skip to main content

Impact of non-compliance on the therapeutic coverage of risperidone – comparison of long acting injectible with oral formulations.

    • Janssen Pharmaceutica

    Research output: Book/Report › Commissioned report

    Original languageEnglish
    PublisherUnknown
    Commissioning bodyJanssen Pharmaceutica
    Edition2002
    Publication statusPublished - 1 Jan 2002

    Cite this